Navigation Links
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
Date:2/27/2008

ive Officer of Forest, said: "This amendment provides an opportunity for Forest to significantly reduce future royalty expenditures for Bystolic resulting in a favorable impact on the overall economics of Bystolic's commercialization program. We have also recaptured co-promotion rights to the product, allowing us to retain more product value in the future. We have been very pleased with our partnership with Mylan thus far and this is a mutually beneficial proposition for the companies."

About Bystolic

Bystolic (nebivolol) is a novel beta blocker that was approved by the FDA in December 2007 and is approved and marketed in more than 65 countries outside of North America. Mylan licensed the U.S. and Canadian rights to Bystolic from Janssen Pharmaceutical N.V. in 2001, and obtained Janssen's consent to sub-license Bystolic to Forest Laboratories in those territories in an initial agreement completed in January 2006. Bystolic is a cardio-selective beta-1 blocker, with vasodilation properties and a favorable tolerability profile. Upon FDA approval, Bystolic has received five years of marketing exclusivity under the Hatch Waxman legislation. In addition there is an issued U.S. pharmaceutical composition of matter patent that expires in 2021, which may offer additional exclusivity.

About Forest Laboratories and Its Products

Forest Laboratories (http://www.frx.com) is a U.S.-based pharmaceutical company dedicated to identifying, developing, and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Campral(R)* (acamprosa
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
2. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
3. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
4. Nanotube forests grown on silicon chips for future computers, electronics
5. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
6. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
7. Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
8. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
9. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
11. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...HAI,Nov.24/PRNewswire-Asia/--NODPharmaceuticalsInc...allowedthepatentapplicationfor,itsnano-particleora...ighlyefficientapproachtoincorporatepeptidesor,prot...veryofdrugs,otherwiseadministeredasinjections.NODt...anymacromoleculardrugssuchasinsulin,interferon,gr...
(Date:11/24/2009)...HAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyannoun...A)hasapprovedthe,investigationalnewdrugapplication...einsulinformulationtotreatdiabetes.ThisIND,approva...y. , Diabetesisadisordercharacteristicofhighb...abetesoftenresultinseveremicro-and,macro-vasculard...
(Date:11/24/2009)... The FBI recently approved the Promega...rticipating in or generating DNA records for the N... Madison, WI USA (PRWEB) -- The FBI recently app...r use by laboratories participating in, or generat... (NDIS). NDIS currently contains more than seven m...
(Date:11/24/2009)...NTURE:HTL , TORONTO,Nov.24/PRNewswire-FirstCa...apitalInc.,aleadingproviderofadvancedlasersystemsa...nicmarkets,todayreportedoperationalandfinancialres...32009Highlights,-Revenuewas$1.46millioncomparedwi...rcentcomparedwith66.1percentinQ3,2008,-Netlossredu...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...s Inc. (BCI), a,biopharmaceutical company utilizin...compounds that promote the growth of new neurons f...iseases, announced today that it raised an,additio...nancing, bringing,the total to $50 million. New in... current investors and Alexandria Real Estate Equi...
...nthera Pharmaceuticals,Inc., a privately held biop... drugs, announced today that Anthera scientists an...ladib (A-002) clinical and,pre-clinical programs a...iology (ATVB) Annual Conference in Atlanta, Georgi... Phase II trials in Varespladib for the,treatment ...
Other Biology Technology:REVISED: BrainCells Inc. Expands Series B Financing to $50 Million 2BrainCells Inc. Expands Series B Financing to $50 Million 2Anthera Presents Data on Varespladib at ATVB Meeting 2
(Date:11/24/2009)...(November 24, 2009) New research on bacterial com...ems reveals predictable temporal patterns, suggest... markers for monitoring climate change in the pola...Proceedings of the National Academy of Sciences E...the six rivers shifted synchronously over time, co...
(Date:11/23/2009)...esearch presents strong evidence that the "synergi...r traffic-related pollution and indoor endotoxin c...e other exposure alone. , Environmental health...ollege of Medicine have shown that children expose... and indoor endotoxin during early life are six ti...
(Date:11/23/2009)...Mass. November 23, 2009 Applied mathematicians d...ta lancifolia ), a characteristic long leaf with a...ples along the edges. The simple cause of the lily... bending during differential growthwas revealed by...m ribbons. , Haiyi Liang, a postdoctoral student...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2The cause behind the characteristic shape of a long leaf revealed 2WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 1WAVE 26apos 3Bs Revolutionary Whole Body Advanced Vibration Exercise Is Now Available in South America 61038 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 1Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 2Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 3Attachment 26amp 3B Emotional Development Expert Teams Up with Miracle Industries LLC to Launch Valuable Parenting Resource 61034 4Thoratec Presentation at Canaccord Adams Conference to be Webcast 6116 1
...(BRONX, NY) Scientists at Albert Einstein College...heir revolutionary new drug-delivery system with a... deadly drug-resistant staph infections in mice. T...sion of the Journal of Investigative Dermatology ...jority of superficial and invasive skin infections...
...ussell A. Mittermeier, the president of Conservati...ty conservation, has received the Roger Tory Peter...ry. , Mittermeier is a renowned field biologist a...an 500 scientific and popular articles, along with...ecies new to science, had seven others named after...
... Calif.) Scientists at UC Santa Barbara have made...human embryonic stem cells function. , They expla... will renew, or will transform to become part of a...y. The study is reported in the May 1 issue of the... bodes well for cancer research, since tumor stem ...
Other Biology News:New technology shows promise against resistant staph infections 2New technology shows promise against resistant staph infections 3Scientists shed light on inner workings of human embryonic stem cells 2Scientists shed light on inner workings of human embryonic stem cells 3
5x MONO-GOAT POLY C'GATE DILUENT from AbD Serotec
ANTIGEN-DOWN ASSAY DILUENT from AbD Serotec
Rabbit Anti-HALOPERIDOL Polyclonal Antibody, Unconjugated from AbD Serotec
TMB PLUS DILUENT from AbD Serotec
Biology Products: